1/28/2021Bio-Thera Files Biologics License Application Avastin Biosimilar with ...

1/27/2021NH Reports Latest Data on Chinese Smoking Control Market

1/26/2021EUSA and BeiGene Announce Acceptance of a Biologics License Applicati...

1/26/2021AstraZeneca Granted Additional Indiciation for Asthma Drug Symbicort T...

1/26/2021Photocure Partners with Asieris MediTech to Commercialize Hexvix in Ma...

1/22/2021Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...

1/22/2021AZ and MSD's Granted Priority Review for New Indication of Lynparza (O...

1/22/2021Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China

1/22/2021Recent Executive Moves

1/21/2021Jemincare Initiates Phase I Trial of Anti-SARS-Cov-2 Neutralizing Anti...

1/21/2021Sinovac Increases Vaccine Production to Ensure Global Supply

1/21/2021Coronavirus in China: 2021 Outlook Brightens for Health Care Operators...

1/21/2021Lesson from China's National Negotiation of Drug Prices in 2020

1/19/2021Innovent Announces an Out-license Deal with PT Etana to Launch Bevaciz...

1/19/2021NMPA Revises Packages Inserts of Pamidronate Disodium Injection

1/19/2021TRACON Granted Priority Review Acceptance of Envafolimab NDA in Chin...

1/18/2021Kyowa Kirin Granted Conditional Approval of Crysvita (burosumab) in Ch...

1/18/2021Top JPMorgan Banker Sees Steady Supply of Chinese Health Care IPOs, Ev...

1/15/2021CDE Issues the Technical Guidelines for Quality Studies of TCM New Dru...

1/15/2021Innovent's sNDA for Sintilimab as Second-line Therapy for Squamous NSC...

1/15/2021JPO Issues Bidding Documents for the Fourth Batch of VBP

1/15/2021Recent Executive Moves

1/14/2021NHSA Highlights Ten Major Tasks in 2021

1/14/2021Chiome and Henlius Sign Greater China Licensing Deal for Anti-TPOR-2 A...

1/14/2021What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...

1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...

1/13/2021Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All

1/13/2021Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum  in C...

1/13/2021BeiGene Granted Chinese Approval of Tislelizumab in Combo with Chemoth...

1/12/2021Swiss Re Sees Short-term Health insurance as Growth Driver in China

Page:109/367 Total number of articles:10998: [First][<<] [107] [108] [109] [110] [111] [>>] [End]